Who is sponsoring NCT03832868?

NCT03832868 is sponsored by Emory University.

What drugs are being tested in NCT03832868?

Interventions in NCT03832868: Pre-visit timing of receipt of the ICDs implantation decision aid, Post-visit timing of receipt of the ICDs implantation decision aid.

What condition does NCT03832868 study?

NCT03832868 studies Implantable Cardioverter-defibrillators (ICDs).

Is NCT03832868 still recruiting?

NCT03832868 is currently completed. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT03832868

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Syngery-Evaluating the Impact of Decision Aid

Completed NA Last updated 12 September 2019

What this trial tests

NA trial testing Pre-visit timing of receipt of the ICDs implantation decision aid in Implantable Cardioverter-defibrillators (ICDs) in 25 participants. Completed in 6 September 2019.

Timeline

20 February 2019

Primary endpoint
6 September 2019

6 September 2019

Quick facts

Lead sponsor	Emory University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	25
Start date	20 February 2019
Primary completion	6 September 2019
Estimated completion	6 September 2019
Sites	3 locations across United States

Drugs / interventions tested

Pre-visit timing of receipt of the ICDs implantation decision aid
Post-visit timing of receipt of the ICDs implantation decision aid

Conditions studied

Implantable Cardioverter-defibrillators (ICDs) — all drugs for Implantable Cardioverter-defibrillators (ICDs) →

Sponsor

Emory University

Who can join

18 and older, any sex, with Implantable Cardioverter-defibrillators (ICDs). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine whether it is better to give patients an implantable cardioverter-defibrillators (ICDs) decision aid before they have their first consultation with an implanting cardiac electrophysiologist or after the consult.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Emory University trials

Trials by the same sponsor.

NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03832868 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing